Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Taylor Brooks

Clinical trials sponsored by Taylor Brooks, explained in plain language.

Trials to join now! 1

Can a Pre-Dose stop a dangerous immune reaction?

Disease control Recruiting now

This early-phase trial tests whether giving siltuximab before epcoritamab can prevent cytokine release syndrome (CRS), a common and sometimes severe side effect. About 20 adults with non-Hodgkin lymphoma will receive siltuximab one hour before their first epcoritamab dose. Resear…

Phase 1 • Sponsor: Taylor Brooks • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC